Skip to main content

Pronota Signs Up for Thermo Fisher Peptide Service

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific yesterday said that Belgian molecular diagnostics firm Pronota is using the firm’s new HeavyPeptide FasTrack service, which provides a selection of crude heavy peptides for more rapid development of protein assays.
 
Thermo Fisher said that the crude peptides are used in mass spectrometry setup to identify the best proteotypic peptides. After customers identify their candidates, Thermo Fisher uses retained crude stock to rapidly produce the final purified heavy peptides as HeavyPeptide Aqua Kits.
 
Pronota uses its own MASStermind mass spec platform for biomarker validation and is developing tests based on the protein biomarkers. The firm also provides pharmaceutical partners with biomarker discovery and validation services.
 
“In the past, we had to wait four to five weeks for purified peptides,” said Katleen Verleysen, vice president of operations and technology development at Pronota. “Now, we get the crude peptides in about 10 days and can start building our assays right away.”
 
Terms of the alliance were not disclosed.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.